Smith & Nephew, GB0009223206

Smith & Nephew stock holds firm after a Hold call

Published on 08/22/2026 at 11:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Smith & Nephew stock drew a Hold consensus on August 22, 2026, while Bank of America disclosed a 2.888834% voting position on August 21, 2026.

Pop-Art-Comic zeigt Chirurgen mit glänzendem Implantat vor buntem Hintergrund
Smith & Nephew plc (ISIN GB0009223206) wird als farbenfrohe Pop-Art-Comic-Szene mit stolzem Chirurgen inszeniert, Illustration mit AI erstellt.

Smith & Nephew plc stock (GB0009223206) opened at GBX 1,069.50 on August 22, 2026, with a market value of £11.72 billion and a 50-day average of GBX 1,129.08. The latest broker update shows a Hold consensus from nine ratings firms, while Bank of America disclosed a 2.888834% voting position in the company on August 21, 2026.

Broker view stays cautious

The consensus rating of Hold comes from six hold calls and three buy calls, and the average twelve-month price objective now stands at GBX 1,310. That compares with JPMorgan's cut to GBX 1,290 and RBC's reduced target of GBX 1,250, both dated August 6, 2026.

The gap between GBX 1,069.50 and the GBX 1,310 average target leaves the shares below the broker midpoint, even after the stock's recent move. The 200-day average of GBX 1,183.24 also sits above the latest opening level, a technical marker that keeps the chart restrained.

Holding pattern on the register

The trading update on August 21, 2026 showed Bank of America Corporation at 2.461592% of voting rights attached to shares and 2.888834% in total after adding financial instruments. That filing also listed 20,613,790 direct voting rights and 3,319,954 voting rights tied to derivatives.

For investors, that combination of a broker Hold and a fresh holdings filing gives the stock a defined but cautious setup. The register change does not alter the business mix, but it adds a concrete date to watch alongside the price action.

Orthopaedics remains core

Smith & Nephew sells knee implants, hip implants, trauma and extremities products, and other reconstruction devices through its Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management segments. Those lines remain the backbone of the company that underpins the current valuation debate.

Shares at a glance

Smith & Nephew plc traded at GBX 1,069.50 on August 22, 2026, with a market capitalization of £11.72 billion. The 50-day moving average was GBX 1,129.08 and the 200-day moving average was GBX 1,183.24.

Fact box

Company: Smith & Nephew plc
ISIN: GB0009223206
Ticker: SN
Exchange: London Stock Exchange
Price (as of August 22, 2026, 4:00 p.m. ET): GBX 1,069.50
Market cap: £11.72 billion (as of August 22, 2026)
Sector / Industry: Health Care / Medical Devices
Index membership: FTSE 100

Disclaimer...

en | GB0009223206 | SMITH & NEPHEW | boerse | 69985382 | bgmi